Febuxostat

3 trials MMusculoskeletal

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

0 Completed trials

3 Sponsors

2 Countries

Phase III

Phase II

Phase III: 1 Phase II: 2

Oversight events:

2 temporary halts across 1 trial

View oversight register →

Indications tested

Gout 1 Lung neoplasm malignant 1

Sponsors using this IMP

Academisch Ziekenhuis Maastricht 1 Assistance Publique Hopitaux De Paris 1 Centre Hospitalier Universitaire Rouen 1

All trials

3 total

Stop Treatment in gout Pending

2024-515714-40-00 Phase II 1 country Assistance Publique Hopitaux De Paris
Boosting osimertinib Blood Brain Barrier penetration in patients with epidermal growth factor receptor mutated non-small cell lung cancer (O… Pending

2025-523033-26-00 Phase II 1 country Academisch Ziekenhuis Maastricht
Non-inferiority study of a new therapeutic strategy for gout: immediate prescription of a hypouricemia treatment, febuxostat, compared to it… Halted

2024-515547-34-00 Phase III 1 country Centre Hospitalier Universitaire Rouen

Showing 1–3 of 3 trials

← All drugs A–Z